# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Cervical cancer

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-10 of 631 results.
Selective Pelvic Lymphadenectomy for IB-IIA Cervical Cancer
Status: Recruiting
Last Changed: Sep 28, 2017
First Received: Sep 28, 2017
Disease(s): Cervical Cancer
Intervention(s): Lymph nodes debulking surgery.
Locations: Fudan university, Shanghai, Shanghai, China
Individualized Precise Radiotherapy With the Guidance of Radiosensitivity of Locally Advanced Cervical Cancer
Status: Recruiting
Last Changed: May 23, 2017
First Received: May 23, 2017
Disease(s): Cervical Cancer
Intervention(s): 18F-FDG PET/CT and Comet assay guide RapidArc, 18F-FDG PET/CT and Comet assay guide IMRT, RapidArc, 7f-IMRT
Locations: Nanjing Medical University Affiliated Suzhou Hospital, Suzhou, Jiangsu, China
Safety and Efficacy of Tisotumab Vedotin in Combination With Other Cancer Agents in Subjects With Cervical Cancer
Status: Recruiting
Last Changed: Jan 11, 2019
First Received: Dec 24, 2018
Disease(s): Cervical Cancer
Intervention(s): Tisotumab Vedotin, Bevacizumab, Pembrolizumab, Carboplatin
Locations: Montana Cancer Consortium, Billings, Montana, United States
Combination Pembrolizumab, Chemotherapy and Bevacizumab in Patients With Cervical Cancer
Status: Recruiting
Last Changed: Apr 16, 2019
First Received: Dec 11, 2017
Disease(s): Cervical Cancer
Intervention(s): Pembrolizumab, Paclitaxel, Cisplatin, Carboplatin, Bevacizumab
Locations: University of Miami, Miami, Florida, United States
A Study in Recurrent or Metastatic Cervical Cancer Patients With PD-L1 Positive Who Failed in Platinum-based Chemotherapy
Status: Not yet recruiting
Last Changed: Jan 18, 2019
First Received: Jan 18, 2019
Disease(s): Cervical Cancer
Intervention(s): GB226
Locations: National Cancer Center/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, Beijing, China
FDG-PET and Circulating HPV in Patients With Cervical Cancer Treated With Definitive Chemoradiation (II)
Status: Not yet recruiting
Last Changed: Apr 19, 2019
First Received: Feb 26, 2019
Disease(s): Cervical Cancer
Intervention(s): [18-F]- FDG - PET
Locations: University Health Network, The Princess Margaret, Toronto, Ontario, Canada
Radiation Therapy Planning by Multi-parametric PET/MRI Imaging in Patients With Cervical Cancer
Status: Not yet recruiting
Last Changed: Sep 03, 2018
First Received: Sep 03, 2018
Disease(s): Cervical Cancer
Intervention(s): 68Ga-NODAGA-E[c(RGDyK)]2, PET/MRI scan instead of only MRI, 68Ga-NODAGA-E[c(RGDyK)]2, PET/MRI scan instead of only MRI
Locations: University Copenhagen, Copenhagen, Denmark
Avelumab With Axitinib in Persistent or Recurrent Cervical Cancer After Platinum-based Chemotherapy
Status: Not yet recruiting
Last Changed: Feb 01, 2019
First Received: Feb 01, 2019
Disease(s): Cervical Cancer
Intervention(s): Avelumab, Axitinib
Locations: The University of Hong Kong, Hong Kong, Hong Kong
Feasibility of Pet-scan at Day 1 of Brachytherapy for Patients With Cervical Cancer
Status: Recruiting
Last Changed: Jul 17, 2018
First Received: Oct 20, 2017
Disease(s): Cervical Cancer
Intervention(s): Brachytherapy, PET-scan
Locations: Centre Oscar Lambret, Lille, France
Rucaparib Maintenance Therapy in Advanced Cervical Cancer
Status: Not yet recruiting
Last Changed: Jan 07, 2019
First Received: Jan 07, 2019
Disease(s): Cervical Cancer
Intervention(s): Rucaparib, Placebo
Locations: Rigshospitalet, Copenhagen, Sjaelland, Denmark
Rigshospitalet, København Ø, Sjaelland, Denmark